Keele Badge

PHA-30031 - Module Specification
School of Pharmacy and Bioengineering
Faculty of Medicine & Health Sciences

For academic year: 2024/25 Last Updated: 09 May 2024

PHA-30031 - Translational Regenerative Medicine
Coordinator: Karina Wright
Lecture Time: See Timetable...
Level: Level 6
Credits: 15
Study Hours: 150
School Office:

Programme/Approved Electives for 2024/25

None

Available as a Free Standing Elective

No

Co-requisites

None

Prerequisites

None

Barred Combinations

None

Description for 2024/25


Aims
The aim of this module is to evaluate cell therapy strategies. This will require an understanding of mechanisms of action, allogeneic/autologous approaches, good manufacturing practice, ethical/regulatory frameworks and the role of patient involvement and engagement.

Intended Learning Outcomes

Evaluate autologous and allogeneic cell therapy approaches with reference to immunological considerations and
mechanisms of action: 1
Demonstrate a thorough understanding of good manufacturing practice and the UK advanced therapy medicinal product regulatory framework: 1
Critically discuss the ethical challenges, surrounding the derivation and use of cell therapies: 1
Reflect on their own personal feelings regarding the use of cell based therapies and the wishes of patients using clinical data sets: 2
Evaluate the role of patient involvement and engagement in the clinical translation of regenerative medicine: 2

Study hours

1x 1-hour introductory lecture
2x 1-hour guest lectures
10x 1-hour case-based learning tutorials
2-hours drop-in support sessions for assessment
72-hours independent study to support case-based learning
63-hours working on assessments

School Rules

None

Description of Module Assessment

1: Reflective Analysis weighted 30%
Reflective account of patient involvement and engagement
Students will be presented with, and asked to complete, a patient questionnaire based on regenerative medicine approaches for the treatment of spinal cord injury. They will then receive real clinical data and be asked to reflect on why patients might have answered differently to their own expected responses. This work should be no more than 1000 words.

2: Report weighted 70%
Concise evaluative report (2000 words in total)
Students will be presented with a specific disease/injury case and asked to formulate an allogeneic and autologous regenerative medicine approach to treatment. In the report, students must include reference to both the regulatory framework and ethical challenges for their chosen case study.

Please note that for the 2022/23 Academic Year programmes may be adapted to operate in accordance with a flexible, digital approach. This means that there may be some changes made to how modules are delivered and assessed. The latest information will be provided to you by your School in module handbooks. We endeavour to give you as much notice as possible of any changes and details about the circumstance in which changes are made to programmes can be found in the Student Agreement, available at: https://www.keele.ac.uk/student-terms-and-conditions/

Last Updated: 09 May 2024